[PLX] YoY Quarter Result on 30-Jun-2014 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Aug-2014
Financial Year
2014
Quarter
30-Jun-2014 [#Q2]
Profit Trend
QoQ- 16.69%
YoY- 10.50%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 6,358 1,769 4,616 2,686 3,064 26,113 764 42.30%
PBT 450 -10,736 -5,071 -6,119 -6,837 22 179 16.59%
Tax 3,045 213 43 202 0 -8,765 20,699 -27.32%
NP 450 -10,853 -5,071 -6,119 -6,837 9,642 -13,689 -
Tax Rate -676.67% - - - - 39,840.91% -11,563.69% -
Total Cost 5,908 12,622 9,687 8,805 9,901 16,471 14,453 -13.83%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 7.08 -613.51 -109.86 -227.81 -223.14 36.92 -1,791.75 -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
EPS 0.04 -0.11 -0.05 -0.07 -0.07 0.11 -0.16 -
EPS Diluted -0.60 -0.11 -0.05 -0.07 -0.07 0.10 -0.16 24.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.